165 related articles for article (PubMed ID: 37124956)
1. Immunohistochemical Analysis of Mitochondrial Ferritin in the Midbrain of Patients with Parkinson's Disease.
Tsubaki H; Yanagisawa D; Kageyama Y; Hafiz Abu Baker Z; Mukaisho KI; Tooyama I
Acta Histochem Cytochem; 2023 Apr; 56(2):21-27. PubMed ID: 37124956
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical Study of Mitochondrial Ferritin in the Midbrain of Patients with Progressive Supranuclear Palsy.
Abu Bakar ZH; Kato T; Yanagisawa D; Bellier JP; Mukaisho KI; Tooyama I
Acta Histochem Cytochem; 2021 Jun; 54(3):97-104. PubMed ID: 34276103
[TBL] [Abstract][Full Text] [Related]
3. Mapping of mitochondrial ferritin in the brainstem of Macaca fascicularis.
Yang M; Yang H; Guan H; Bellier JP; Zhao S; Tooyama I
Neuroscience; 2016 Jul; 328():92-106. PubMed ID: 27133573
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a Novel Monoclonal Antibody against Human Mitochondrial Ferritin and Its Immunohistochemical Application in Human and Monkey Substantia Nigra.
Yang M; Yang H; Guan H; Kato T; Mukaisho K; Sugihara H; Ogasawara K; Terada T; Tooyama I
Acta Histochem Cytochem; 2017 Feb; 50(1):49-55. PubMed ID: 28386150
[TBL] [Abstract][Full Text] [Related]
5. LC3/FtMt Colocalization Patterns Reveal the Progression of FtMt Accumulation in Nigral Neurons of Patients with Progressive Supranuclear Palsy.
Abu Bakar ZH; Bellier JP; Yanagisawa D; Kato T; Mukaisho KI; Tooyama I
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008961
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial ferritin in neurodegenerative diseases.
Yang H; Yang M; Guan H; Liu Z; Zhao S; Takeuchi S; Yanagisawa D; Tooyama I
Neurosci Res; 2013; 77(1-2):1-7. PubMed ID: 23916831
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial ferritin in the regulation of brain iron homeostasis and neurodegenerative diseases.
Gao G; Chang YZ
Front Pharmacol; 2014; 5():19. PubMed ID: 24596558
[TBL] [Abstract][Full Text] [Related]
8. Mitochondrial ferritin protects SH-SY5Y cells against H
Guan H; Yang H; Yang M; Yanagisawa D; Bellier JP; Mori M; Takahata S; Nonaka T; Zhao S; Tooyama I
Exp Neurol; 2017 May; 291():51-61. PubMed ID: 28163159
[TBL] [Abstract][Full Text] [Related]
9. Progressive supranuclear palsy affects both the substantia nigra pars compacta and reticulata.
Hardman CD; Halliday GM; McRitchie DA; Cartwright HR; Morris JG
Exp Neurol; 1997 Mar; 144(1):183-92. PubMed ID: 9126169
[TBL] [Abstract][Full Text] [Related]
10. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
11. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
Novikova L; Garris BL; Garris DR; Lau YS
Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial ferritin expression in erythroid cells from patients with alpha-thalassaemia.
Putburee R; Jetsrisuparb A; Fucharoen S; Tripatara A
Hematology; 2018 Dec; 23(10):844-848. PubMed ID: 29993346
[TBL] [Abstract][Full Text] [Related]
13. Quantitative assessment of iron deposition in the midbrain using 3D-enhanced T2 star weighted angiography (ESWAN): a preliminary cross-sectional study of 20 Parkinson's disease patients.
Wang C; Fan G; Xu K; Wang S
Magn Reson Imaging; 2013 Sep; 31(7):1068-73. PubMed ID: 23746648
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial ferritin limits oxidative damage regulating mitochondrial iron availability: hypothesis for a protective role in Friedreich ataxia.
Campanella A; Rovelli E; Santambrogio P; Cozzi A; Taroni F; Levi S
Hum Mol Genet; 2009 Jan; 18(1):1-11. PubMed ID: 18815198
[TBL] [Abstract][Full Text] [Related]
15. Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia.
Dexter DT; Carayon A; Javoy-Agid F; Agid Y; Wells FR; Daniel SE; Lees AJ; Jenner P; Marsden CD
Brain; 1991 Aug; 114 ( Pt 4)():1953-75. PubMed ID: 1832073
[TBL] [Abstract][Full Text] [Related]
16. Differences in Gene Expression Profiles and Phenotypes of Differentiated SH-SY5Y Neurons Stably Overexpressing Mitochondrial Ferritin.
Mendsaikhan A; Takeuchi S; Walker DG; Tooyama I
Front Mol Neurosci; 2018; 11():470. PubMed ID: 30670947
[TBL] [Abstract][Full Text] [Related]
17. Comparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.
Yue X; Hariri DJ; Caballero B; Zhang S; Bartlett MJ; Kaut O; Mount DW; Wüllner U; Sherman SJ; Falk T
Neuroscience; 2014 Jan; 258():385-400. PubMed ID: 24291725
[TBL] [Abstract][Full Text] [Related]
18. Mitochondrial Ferritin Protects Hydrogen Peroxide-Induced Neuronal Cell Damage.
Gao G; Zhang N; Wang YQ; Wu Q; Yu P; Shi ZH; Duan XL; Zhao BL; Wu WS; Chang YZ
Aging Dis; 2017 Jul; 8(4):458-470. PubMed ID: 28840060
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial ferritin in the substantia nigra in restless legs syndrome.
Snyder AM; Wang X; Patton SM; Arosio P; Levi S; Earley CJ; Allen RP; Connor JR
J Neuropathol Exp Neurol; 2009 Nov; 68(11):1193-9. PubMed ID: 19816198
[TBL] [Abstract][Full Text] [Related]
20. Sequence variations in mitochondrial ferritin: distribution in healthy controls and different types of patients.
Castiglioni E; Finazzi D; Goldwurm S; Levi S; Pezzoli G; Garavaglia B; Nardocci N; Malcovati L; Porta MG; Gallì A; Forni GL; Girelli D; Maccarinelli F; Poli M; Ferrari M; Cremonesi L; Arosio P
Genet Test Mol Biomarkers; 2010 Dec; 14(6):793-6. PubMed ID: 20939738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
